Shilpa Medicare partners with Orion for Recombinant Human Albumin for European market
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The company has posted net profit of Rs. 40.88 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Global Health has posted net profit of Rs. 481.43 crores for the Financial Year ended March 31, 2025
CRL shall invest another Rs. 200 crore for creation of additional beds
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated